Day: October 23, 2024

LAKE FOREST, Ill., Oct. 23, 2024 (GLOBE NEWSWIRE) — Pactiv Evergreen (NASDAQ: PTVE) today announced the following details for its third quarter 2024 earnings release and teleconference call.Earnings Release: Tuesday, November 12, 2024, at 6:05 a.m. EDTWebcast and Teleconference: Tuesday, November 12, 2024, at 8:30 a.m. EDTPactiv Evergreen Participants: Michael King, President and Chief Executive Officer  Jon Baksht, Chief Financial Officer  Curt Worthington, VP, Strategy & Investor Relations   Participants may access the live webcast on the Company’s Investor Relations website at https://investors.pactivevergreen.com/news-events/events-presentations. Participants can also dial 877-317-6789 (domestic) or 412-317-6789 (international) to listen to the live call. A replay will be available on the company’s...

Bold Eagle Will Feature a Warrantless Structure Each Unit Includes One Class A Ordinary Share and One Eagle Share Right to Receive 1/20th of a Class A Ordinary Share Sponsor to Reduce Founder Shares in an Amount Equal to the Shares Underlying the Eagle Share Rights NEW YORK, NY, Oct. 23, 2024 (GLOBE NEWSWIRE) — Bold Eagle Acquisition Corp. (the “Company”), the ninth public acquisition vehicle sponsored by Eagle Equity Partners, which is led by Harry Sloan, Jeff Sagansky and Eli Baker, today announced the pricing on October 23, 2024 of its initial public offering of 25,000,000 units at a price of $10.00 per unit. Each unit consists of one Class A ordinary share and one Eagle Share Right to receive one twentieth of one Class A ordinary share upon the consummation of an initial business combination. There are no warrants issued publicly...

MELBOURNE, Australia, Oct. 24, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara®1), an agent for the imaging of glioma. The application has been granted priority review and designated a PDUFA2 goal date of 26 April 2025, paving the way for a U.S. commercial launch in 20253. Pixclara (18F-floretyrosine or 18F-FET) is a PET agent for the characterisation of progressive or recurrent glioma from treatment related changes in both adult and pediatric patients. FET PET is already included in international clinical practice guidelines for the imaging of gliomas4, however there is currently no FDA-approved targeted amino acid PET agent for adult and pediatric...

CALGARY, Alberta, Oct. 23, 2024 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) will announce its third quarter 2024 financial results on Thursday, November 7, 2024, after the market closure. Senior Management will hold a Conference Call to discuss results on Friday, November 8, 2024, at 8:00 a.m. MT / 10:00 a.m. ET. The conference call may be accessed by dial in or via webcast:Pre-register for the Conference Call: https://dpregister.com/sreg/10194106/fdd9255e96Dial In Toll Free: 1-844-784-1724Participant International Dial In: 1-412-317-6716Canada Toll Free: 1-866-450-4696Colombia Toll Free: 01800-9-156803UK Toll Free: 08082389064Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=hgOqTR3sAll remarks...

BOCA RATON, Florida, Oct. 23, 2024 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the third quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024. Management will host a conference call and audio webcast on Thursday, November 7, 2024, at 4:30 p.m. ET to discuss the Company’s financial results.Event: Third Quarter 2024 Financial Results Conference CallDate: Thursday, November 7, 2024Time: 4:30 p.m. Eastern TimeLive Call: 1-844-826-3033 (U.S. & Canada Toll-Free)Conference ID 10192492Webcast: RegisterFor interested individuals unable to join the conference call, a webcast of the call will be available for one...

TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) — KMT-Hansa Corp. (the “Corporation”) is pleased to announce that, further to its press release dated September 27, 2024, the Corporation issued an aggregate of 10,008,714 units (the “Units”) of the Corporation at a price of $0.035 per Unit for aggregate gross proceeds of $350,305. Each Unit is comprised of one (1) common share and one-half (½) of one common share purchase warrant (“Warrant”). Each whole Warrant entitles the holder thereof to purchase one (1) common share at an exercise price of $0.05 per Warrant at any time until 5:00 p.m. on October 21, 2025. In connection with the issuance of the Units, the Corporation paid a finder’s fees of $34,100 in cash to an arm’s length third party. The securities issued pursuant to the private placement are subject to resale restrictions expiring...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF | FRA: Z36) (“CLM” or the “Company”) announces today that it has amended the terms of its previously announced non-brokered private placement financing (the “Initial Offering”). The Initial Offering previously consisted of up to 15,000,000 common shares of the Company issued on a “flow-through basis” at a price of $0.02 per share for gross proceeds of up to $300,000. The Company now intends to issue up to 12,000,000 units (each, a “Unit”) at a price of $0.025 per Unit for gross proceeds of up to $300,000 (the “Revised Offering”). Each Unit will be issued on a “flow-through basis” and will consist of one common share of the Company and...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) — Nevada King Gold Corp. (TSX-V: NKG) (“Nevada King” or the “Company”) is pleased to announce that the Company has entered into an agreement with Desjardins Capital Markets (“Desjardins”) on behalf of a syndicate of agents (the “Agents”) in connection with the private placement offering of up to 29,411,764 common shares (the “Common Shares”) of the Company at a price of $0.34 (the “Offer Price”) per Common Share for aggregate gross proceeds to the Company of up to $10,000,000 (the “Offering”). The net proceeds of the Offering are intended to be used to advance Nevada King’s Atlanta Gold Mine Project and for general corporate purposes. The Common Shares to be issued under the...